These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 2752490)

  • 1. Comparative pharmacokinetics of acetohexamide and its metabolite, hydroxyhexamide in laboratory animals.
    Asada S; Nagamine S; Nakae H
    Chem Pharm Bull (Tokyo); 1989 Mar; 37(3):760-5. PubMed ID: 2752490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypoglycemic effect of S(-)-hydroxyhexamide, a major metabolite of acetohexamide, and its enantiomer R(+)-hydroxyhexamide.
    Imamura Y; Sanai K; Seri K; Akita H
    Life Sci; 2001 Sep; 69(16):1947-55. PubMed ID: 11693275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sex-dependent pharmacokinetics of S(-)-hydroxyhexamide, a pharmacologically active metabolite of acetohexamide, in rats.
    Imamura Y; Kaneko M; Takada H; Otagiri M; Shimada H; Akita H
    Comp Biochem Physiol C Toxicol Pharmacol; 2002 Dec; 133(4):587-92. PubMed ID: 12458186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo and in vitro binding of (-)-hydroxyhexamide, a major metabolite of acetohexamide, to rabbit serum.
    Imamura Y; Abe H; Kojima Y; Otagiri M
    J Pharmacobiodyn; 1989 Aug; 12(8):503-7. PubMed ID: 2614641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Interconversion model analysis for acetohexamide and its metabolite, hydroxyhexamide in the rat by application of the simultaneous multi-lines fitting technique].
    Nagamine S; Nakae H; Asada S
    Yakugaku Zasshi; 1988 Nov; 108(11):1072-80. PubMed ID: 3251017
    [No Abstract]   [Full Text] [Related]  

  • 6. Mechanism of pharmacodynamic and pharmacokinetic interactions between acetohexamide and phenylbutazone in rabbits.
    Imamura Y; Nomura T; Katsuki Y; Kojima Y; Otagiri M
    Pharmacol Toxicol; 1990 Nov; 67(5):415-9. PubMed ID: 2096386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of simultaneous administration of drugs on absorption and excretion. XIX. Binding of acetohexamide and its major metabolite, (-)-hydroxyhexamide, to human serum albumin.
    Imamura Y; Kojima Y; Ichibagase H
    Chem Pharm Bull (Tokyo); 1985 Mar; 33(3):1281-4. PubMed ID: 4028305
    [No Abstract]   [Full Text] [Related]  

  • 8. A case of acetohexamide-induced hypoglycemia: the influence of hypothyroidism on the metabolism of acetohexamide.
    Shibutani Y; Yokota T
    Nihon Naibunpi Gakkai Zasshi; 1991 Jan; 67(1):42-9. PubMed ID: 2013345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stereoselective reduction of acetohexamide in cytosol of rabbit liver.
    Imamura Y; Kojima Y; Higuchi T; Akita H; Oishi T; Otagiri M
    J Pharmacobiodyn; 1989 Dec; 12(12):731-5. PubMed ID: 2699749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A study of certain factors which might modify the pharmacological action of hydroxyhexamide, an active metabolite of the oral hypoglycemic agent: acetohexamide (author's transl)].
    Raymond Y; Dubuc JC
    Ann Pharm Fr; 1978; 36(11-12):593-601. PubMed ID: 38731
    [No Abstract]   [Full Text] [Related]  

  • 11. Differential pharmacokinetics of acetohexamide in male Wistar-Imamichi and Sprague-Dawley rats: role of microsomal carbonyl reductase.
    Imamura Y; Shimada H
    Biol Pharm Bull; 2005 Jan; 28(1):185-7. PubMed ID: 15635190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sex-dependent pharmacokinetics and in vitro reductive metabolism of acetohexamide in Wistar-Imamichi rats.
    Imamura Y; Kaneko M; Mori Y; Otagiri M
    Biol Pharm Bull; 1999 Apr; 22(4):435-8. PubMed ID: 10328570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Further studies on reductive metabolism of acetohexamide in heart.
    Imamura Y; Higuchi T; Kojima Y; Otagiri M
    Chem Pharm Bull (Tokyo); 1989 Jul; 37(7):1941-3. PubMed ID: 2805175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The determination of essential clearance, volume, and residence time parameters of recirculating metabolic systems: the reversible metabolism of methylprednisolone and methylprednisone in rabbits.
    Ebling WF; Jusko WJ
    J Pharmacokinet Biopharm; 1986 Dec; 14(6):557-99. PubMed ID: 3820091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [High-performance liquid chromatographic determination of acetohexamide and its metabolite, hydroxyhexamide (author's transl)].
    Takagishi Y; Sato K; Tomita K; Sakamoto T
    Yakugaku Zasshi; 1979 Sep; 99(9):961-3. PubMed ID: 547059
    [No Abstract]   [Full Text] [Related]  

  • 16. GLC determination of acetohexamide and hydroxyhexamide in biological fluids.
    Kleber JW; Galloway JA; Rodda BE
    J Pharm Sci; 1977 May; 66(5):635-8. PubMed ID: 874743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Species difference in the in vitro metabolic reduction of acetohexamide.
    Imamura Y; Kojima Y; Otagiri M
    Chem Pharm Bull (Tokyo); 1988 Oct; 36(10):4199-202. PubMed ID: 3245995
    [No Abstract]   [Full Text] [Related]  

  • 18. Acetohexamide hypoglycemia: treatment by peritoneal dialysis.
    Black WD; Acchiardo SR
    South Med J; 1977 Oct; 70(10):1240-1. PubMed ID: 910178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic reduction of acetohexamide in rat kidney: sex difference and effect of streptozotocin-induced diabetes.
    Kojima Y; Imamura Y; Otagiri M
    J Pharmacobiodyn; 1988 May; 11(5):309-13. PubMed ID: 2971793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of interconversion pharmacokinetics of 16α-hydroxycleroda-3,13(14)Z-dien-15,16-olide - a novel HMG-CoA reductase inhibitor and its acid metabolite using multi-compartmental pharmacokinetic model in mice.
    Laxman TS; Puttervu SK; Mishra A; Verma S; Singh SP; Sashidhara KV; Marandi CM; Saxena S; Yadav MK; Bhatta RS
    Xenobiotica; 2019 Apr; 49(4):474-483. PubMed ID: 29565234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.